Executive Summary
The top 30 federal contracts totaling $91.7B underscore sustained U.S. government commitment to nuclear remediation (DOE: ~$57B), space exploration (NASA: ~$28B), and IT/defense services (GSA: multiple $100M+ awards), driving long-term revenue stability for primes like Fluor, Boeing, Jacobs, and SpaceX through 2026-2030. 28 bullish signals dominate, with 77% average outlay realization on mature contracts signaling low execution risk and $20B+ in exercisable options for upside. Neutral signals limited to nonprofit lab operators (Argonne, Stanford) highlight non-commercial stability without fee margins.
Tracking the trend? Catch up on the prior General Federal Contracts digest from December 22, 2025.
Investment Signals(4)
- DOE Nuclear Dominance(HIGH)▲
Four contracts exceed $56B in obligations for Savannah River Site, Argonne Lab, SLAC accelerator, and Hanford tank waste, with $19.7B already outlayed, signaling multi-decade revenue for Fluor subsidiary and tank ops LLC.
- NASA Space Continuity(HIGH)▲
Boeing's $22B ISS contract plus $6B+ across SpaceX, KBR, Syncom/Jacobs, Aerodyne-SGT, and Lockheed ensure $28B+ through 2027-2030, with 50%+ outlays on key awards indicating paced funding.
- GSA IT/Defense Surge(MEDIUM)▲
10 GSA awards total $2.6B+ obligations (up to $6B+ options) for IT, engineering, and analysis services to Booz Allen, CACI, Peraton, and General Dynamics, many 2023-2024 awards with 5-year horizons.
- Nonprofit Lab Stability(HIGH)▲
$31B DOE lab ops contracts to UChicago Argonne and Stanford provide reimbursement funding without fees, $9.6B outlayed but no profit margins.
Risk Flags(3)
- Execution[HIGH RISK]▼
13 contracts with $0 outlay despite $3.5B+ obligations (e.g., BL Harbert $730M embassy, recent GSA IT awards) signal potential delays in funding or starts.
- Competitive[MEDIUM RISK]▼
15 contracts end 2025-2027 ($60B+ value: Savannah River, Boeing ISS, Syncom, Hanford), risking recompetes post-2026.
- Execution[MEDIUM RISK]▼
Cost-plus award fee prevalent (18 contracts) ties ~40% of fees to performance; firm-fixed price (9 contracts) exposes to overruns on $2B+.
Opportunities(3)
- ◆
$20B+ unexercised options across 25 contracts (e.g., McKesson CDC $8.1B ceiling, Booz Allen GSA $2.6B) offer 20-50x obligation upside if exercised.
- ◆
HHS/CMS health IT and distribution contracts ($1B+: Noridian, Companion Data, McKesson) signal recurring vaccine/claims processing needs through 2028-2029.
- ◆
Small/SDVOSB set-asides (Blues Taq $649M ceiling, Aerodyne-SGT $531M, Development Infrastructure) position for non-competitive follow-ons amid $1B+ obligations.
Sector Themes(3)
- ◆
$57B DOE contracts (60% of total) with 40% outlayed emphasize long-term waste/tank/site management through 2026-2027.
- ◆
NASA's $28B (30% of total) spans ISS, crew transport, facilities to 2030, with cost-plus structures mitigating risk.
- ◆
GSA/HHS/Treasury awards >$4B for data centers, engineering, claims processing signal multi-year digitization push.
Watch List(4)
- 👁
{"entity"=>"Fluor Corporation (Savannah River)", "reason"=>"$25B obligation (largest), 36% outlayed, ends 2026-09-30 with $11.7B options.", "trigger"=>"Recompete RFP or extension announcement"}
- 👁
{"entity"=>"Boeing (ISS)", "reason"=>"$22B mega-contract, low 11% outlay pace signals funding risks through 2026.", "trigger"=>"NASA FY2026 outlay acceleration >20%"}
- 👁
{"entity"=>"McKesson (CDC Vaccine)", "reason"=>"$152M obligated but $8.1B options ceiling for distribution through 2029.", "trigger"=>"Option exercise >$500M"}
- 👁
{"entity"=>"BL Harbert (Beirut Embassy)", "reason"=>"$730M firm-fixed with $0 outlay after 8+ years flags delay risks.", "trigger"=>"First outlay >$50M or termination"}
Get daily alerts with 4 investment signals, 3 risk alerts, 3 opportunities and full AI analysis of all 30 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC